Abstract
Severe alcoholic hepatitis has a high mortality rate due to limited therapeutic methods. Although corticosteroids have been used to control the inflammatory response, the outcomes vary and no standardized therapy has been established. Novel therapeutic approaches, such as anti-TNF-α, pentoxifilline, and others have been tested clinically on the basis of their cytokinemic pathophysiology with limited success. However, treatment of leukocytosis that causes cytokinemia and hepatic inflammation in patients via granulocytapheresis and leukocytapheresis showed promising results in a number of reports. Here, we report two cases of severe alcoholic hepatitis treated with granulocytapheresis. The liver function and inflammation recovered after the therapy. A review of 35 cases treated with granulocytapheresis and leukocytapheresis demonstrated their efficacy in treating alcoholic hepatitis by controlling leukocytosis as well as cytokines such as IL-8. Multidisciplinary treatment for severe alcoholic hepatitis should be considered case by case on the basis of the complexity and severity of the condition.
References
Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758–2769.
Horie Y, Yamagishi Y, Ebinuma H, et al. Therapeutic strategies for severe alcoholic hepatitis. Clin Res Hepatol Gastroenterol. 2011;35:738–744.
Nguyen KE, Thevenot T, Piquet MA, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med. 2011;365:1781–1789.
Boetticher NC, Peine CJ, Kwo P, et al. A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology. 2008;135:1953–1960.
Parker R, Armstrong MJ, Corbett C, et al. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Aliment Pharmacol Ther. 2013;37:845–854.
Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011;365:1790–1800.
Tamura S, Sugawara Y, Kukudo N. Early liver transplantation for severe alcoholic hepatitis [Letter to Editor]. N Engl J Med. 2012;366:477–478.
Kamimura K, Kobayashi M, Mori S, et al. A case of severe alcoholic hepatitis treated with Granulocytapheresis (Article in Japanese). Kanzo. 2002;43:316–321.
Narita R, Sasakura S, Yokota M, et al. Successful treatment of severe alcoholic hepatitis with plasma exchange and leukapheresis-report of a case (Article in Japanese). Nihon Shokakibyo Gakkai Zasshi. 1998;95:51–55.
Tuji Y, Sakamoto Y, Tanabe R, et al. Survive of severe alcoholic hepatitis with leukocytapheresis-report of a case (Article in Japanese). Alc Biomed Res. 2002;22:113–119.
Naito M, Horiike S, Iwasa M, et al. Severe alcoholic hepatitis resulting in liver transplantation: the first case in Japan (Article in Japanese). Nihon Naika Gakkai Zasshi. 2005;94:753–755.
Okubo K, Yoshizawa K, Okiyama W, et al. Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis. Intern Med. 2006;45:155–158.
Ikeda Y, Takano Y, Sato Y, et al. Case (Article in Japanese). Rinshoshokakinaika. 2008;23:507–512.
Ota Y, Sasada Y, Nakahodo J, et al. A case of severe alcoholic hepatitis successfully treated by granulocytapheresis (Article in Japanese). Nihon Shokakibyo Gakkai Zasshi. 2009;106:1778–1782.
Kumashiro R, Koga Y, Kuwahara R, et al. Granulocytapheresis (GCAP) for severe alcoholic hepatitis—A preliminary report. Hepatol Res. 2006;36:229–236.
Mori S, Horie Y, Yamagishi Y, et al. Survive of severe alcoholic hepatitis with granulocyte and monocyte apheresis (Article in Japanese). Alcohol Biomed Res. 2004;24:114–119.
Morris JM, Dickson S, Neilson M, et al. Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series. Eur J Gastroenterol Hepatol. 2010;22:457–460.
Umeda R, Yamagishi Y, Horie Y, et al. Consideration about after course and outcome as a novel therapeutic intervention in severe alcoholic hepatitis (Article in Japanese). Alcohol Biomed Res. 2012;31:66–70.
Horie Y. Granulocytapheresis and plasma exchange for severe alcoholic hepatitis. J Gastroenterol Hepatol. 2012;27:99–103.
Takada A, Tsutsumi M. National survey of alcoholic liver disease in Japan (1968–91). J Gastroenterol Hepatol. 1995;10:509–516.
Mathurin P, O’Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255–260.
Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1984;8370:179–182.
Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol. 1991;12:162–169.
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.
Cohen SM, Ahn J. Review article: the diagnosis and management of alcoholic hepatitis. Aliment Pharmacol Ther. 2009;30:3–13.
Rambaldi A, Saconato HH, Christensen E, et al. Systematic review: glucocorticosteroids for alcoholic hepatitis—a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther. 2008;27:1167–1178.
Huang YS, Chan CY, Wu JC, et al. Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. J Hepatol. 1996;24:377–384.
Acknowledgments
We acknowledge Takao Tsuchida from the Division of Gastroenterology and Hepatology at Niigata University for the excellent assistance in histological staining. The authors would like to thank Enago for the English language review.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Notice
The clinical course of case 1 is from Kamimura K et al. Kanzo (2002) 43:316-321 with permission from the Japan Society of Hepatology.
Rights and permissions
About this article
Cite this article
Kamimura, K., Imai, M., Sakamaki, A. et al. Granulocytapheresis for the Treatment of Severe Alcoholic Hepatitis: A Case Series and Literature Review. Dig Dis Sci 59, 482–488 (2014). https://doi.org/10.1007/s10620-013-2871-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-013-2871-y